[PDF] Top 20 El concepto de reparación integral y su aplicación en Colombia y Ecuador
Has 10000 "El concepto de reparación integral y su aplicación en Colombia y Ecuador" found on our website. Below are the top 20 most common "El concepto de reparación integral y su aplicación en Colombia y Ecuador".
Update on the medical treatment of Graves’ ophthalmopathy
... RCTs enrolled patients with moderately severe GO, although inclusion criteria ranged from one trial that enrolled patients solely with mild GO to another that enrolled patients with moderate to severe ... See full document
5
Medical treatment of endometriosis: an update
... This review focuses on the most recent discoveries regarding medical treatment of endometriosis. This is an evidence based narrative review conducted by searching Medline up to (2017) and other online ... See full document
152
Update on medical treatment for Cushing’s disease
... first medical treatment to be approved by the European Medicines Association (EMA) and the United States Federal Drug Association (FDA), for the treatment of CD after unsuccessful pituitary surgery ... See full document
25
Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
... visit, respectively. Detailed observations were available for 18 patients out of the 29 patients. Figure 4 shows the course of the eye symptoms in these patients. Out of all the eye symptoms observed, only the value of ... See full document
11
A novel method for quantifying the biomechanical parameters of orbital soft tissue using a corneal dynamic scheimpflug analyser: a retrospective study
... with Graves ophthalmopathy were included in the ...with Graves ophthal- mopathy and exophthalmometry, severity and activity of Graves ophthalmopathy and orbit computed tomography (CT) ... See full document
11
Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface
... immunosuppressive treatment is typic- ally less effective in smokers [60, 62, 64, ...[66]. Treatment with anti-thyroid medi- cation was negatively correlated with developing TAO but smoking increased ... See full document
8
Orbital positron emission tomography/computed tomography (PET/CT) imaging findings in graves ophthalmopathy
... This prospective, observational, cross-sectional study was carried out in the Thyroid Clinic of the “Conde de Valenciana” Ophthalmology Institute. The study was ap- proved by the “Instituto de Oftalmología, Fundación ... See full document
10
Current and emerging treatment options for Graves’ hyperthyroidism
... 35 studies involving over 7000 patients, total thyroidectomy was equally safe, with 0.9% recurrent laryngeal nerve palsy (RLN), 0.9% permanent hypoparathyroidism and no recurrent disease. Subtotal thyroidectomy resulted ... See full document
32
Original endoscopic orbital decompression of lateral wall through hairline approach for Graves’ ophthalmopathy: an innovation of balanced orbital decompression
... Capital Medical University for revising and proofreading the ...new medical technology in the Second Xiangya Hospital of Central South University, Changsha, Hunan, ... See full document
13
Novel single-nucleotide polymorphisms in the calsequestrin-1 gene are associated with Graves’ ophthalmopathy and Hashimoto’s thyroiditis
... with Graves’ disease with or without GO, presence or absence of other autoimmune diseases, and presence or absence of eth- nic differences in the different groups of patients are shown in Table ...The ... See full document
12
The relationship between Graves’ ophthalmopathy and dry eye syndrome
... damage. Treatment for DES should be carefully considered in the context of GO, as some treatments for GO may contribute to dry eye ...multiple treatment considerations that can be used to help with DES in ... See full document
10
<p>Prevalence of increased intraocular pressure in patients with Graves’ ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran</p>
... We propose a detailed eye examination for all subjects who are diagnosed with Graves ’ disease. Our results cor- responded with numerous other studies with slight epide- miologic variations. Early diagnosis and ... See full document
8
Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves’ ophthalmopathy
... major medical treatment methods to modify the disease course are high-dose steroids and radi- ation ...steroid treatment is tapered or withdrawn ... See full document
10
Association of TLR7 and TSHR copy number variation with Graves’ disease and Graves’ ophthalmopathy in Chinese population in Taiwan
... with ophthalmopathy (GO) recruited from China Medical University Hospital in ...China Medical University Hospital gave its approval for the ... See full document
5
Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?
... 9 Kulig G, Andrysiak-Mamos E, Sowinska-Przepiera E, et al. Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with ... See full document
181
Ophthalmopathy of Graves' disease: computerized volume measurements of the orbital fat and muscle
... Pixel-calibrated volume measurements of muscle and fat in the bony orbit were made from CT scans of 72 patients with Graves' disease, with and without ophthalmopathy, to define character[r] ... See full document
35
Calsequestrin is Decreased in the Thyroid Gland of Patients with Graves’ Disease – Further Evidence for a Role of Autoimmunity against this Protein in Graves’ Ophthalmopathy
... upregulated in the thyroid tissues from patients with GO compared to those patients without eye disease [15]. In this study we also studied thyroid tissue from a few patients with toxic nodular goitre, in whom levels of ... See full document
11
Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas
... Phase II and III trials have shown that trabectedin used as a single agent is not correlated with any grade of toxicity in about 91% of cases, with grade 3 and 4 adverse events occur- ring in only about 10% of cases. The ... See full document
11
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsy
... of treatment with one or two ...12-week treatment period followed by a 1-week tapering ...active treatment and placebo groups: a statistically significant difference was observed only between once ... See full document
5
Update on the clinical utility of sildenafil in the treatment of pulmonary arterial hypertension
... of therapy on disease remodeling overall survival have yet to be completed. Combination therapy is an exciting develop- ment in the treatment of PAH. A favorable side effect profile and acceptable dosing regimen ... See full document
21
Related subjects